IVERIC bio Inc.

NASDAQ: ISEE · Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM

IVERIC bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-72.23M -59.06M -42.35M -49.26M -34.54M -33.03M -24.55M -30.14M -26.8M
Depreciation & Amortization
70K 58K 35K 24K 21K 15K 6K 5K 13K
Stock-Based Compensation
11.9M 8.35M 6.56M 6.39M 5.39M 4.25M 2.63M 2.08M 2.29M
Other Working Capital
15.35M -8.91M -8.46M 3.82M -1.12M 1.29M -3.96M 5.59M 454K
Other Non-Cash Items
-870K -1.31M 82K 240K 300K 318K 176K 347K 395K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
10.54M 2.73M -5.44M 6.7M -8.68M 6.02M -4.47M 7.26M -5.36M
Operating Cash Flow
-50.59M -49.23M -41.12M -35.91M -37.51M -22.43M -26.22M -20.45M -29.46M
Capital Expenditures
-233K -296K -229K -95K -116K -361K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a -21.3M n/a n/a n/a
Purchase of Investments
n/a -65.57M -68.97M -47.6M -48.9M -86.58M -16.93M -12.6M -26.71M
Sales Maturities Of Investments
39.51M 63.5M 72.58M 30.05M 14.87M 28.03M 63.81M 53.63M 19M
Other Investing Acitivies
n/a 500K n/a n/a n/a 21.3M n/a n/a n/a
Investing Cash Flow
39.27M -1.87M 3.38M -17.65M -34.15M -58.9M 46.88M 41.03M -7.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.59M 374.31M 49.72M 2.8M 2.08M 162.91M 108.85M 448K 129K
Financial Cash Flow
2.59M 374.31M 49.72M 2.8M 2.08M 162.91M 108.85M 448K 129K
Net Cash Flow
-8.73M 323.2M 11.99M -50.75M -69.58M 81.57M 129.52M 21.03M -37.04M
Free Cash Flow
-50.83M -49.53M -41.34M -36M -37.63M -22.8M -26.22M -20.45M -29.46M